Compare GLP-1 medicines in the US
Head-to-head pages: how the medicines differ in what they’re approved for, how they’re taken, side effects, cost and coverage in the US. Neutral and sourced, never a recommendation: your doctor decides which, if any, fits.
Comparisons
-
GLP-1 vs bariatric surgery: how do weight loss, risks, cost and coverage compare in the US?
No trial has compared bariatric surgery with Wegovy or Zepbound yet. What separate US studies and trials show on weight, risks, cost and Medicare coverage.
-
Wegovy pill vs Foundayo vs Wegovy injection: how do the GLP‑1 pills differ from the shot?
Two daily GLP-1 pills are FDA-approved for weight: the Wegovy pill and Foundayo. How you take each, trial results, side effects and cash prices vs the shot.
-
Mounjaro vs Ozempic: how do blood sugar, weight loss, side effects and cost compare?
In SURPASS-2, adults with type 2 diabetes lost 17 to 25 lb on Mounjaro and 13 lb on Ozempic 1 mg over 40 weeks. Side effects, cash prices and Medicare.
-
Mounjaro vs Zepbound: what is the difference, and why is coverage different?
Mounjaro and Zepbound are both tirzepatide. Mounjaro is approved for type 2 diabetes, Zepbound for weight and sleep apnea, so US plans cover them differently.
-
Ozempic vs Wegovy: same medicine, so what is the difference in dose, weight loss, cost and coverage?
Both contain semaglutide. Ozempic is for type 2 diabetes up to 2 mg; Wegovy for weight and heart risk at 2.4 mg. Trial results, cash prices and coverage.
-
Zepbound vials vs KwikPen vs pen: which forms are there, and which does Medicare cover?
Zepbound comes as a single-dose pen, vials and a 4-dose KwikPen. How each is used and stored, Lilly’s self-pay prices, and which form Medicare covers.
-
Zepbound vs Wegovy: which loses more weight, and how do side effects, cost and coverage compare?
In the SURMOUNT-5 head-to-head, Zepbound gave 20.2% weight loss vs 13.7% for Wegovy at 72 weeks. Side effects, cash prices and who covers which.
